Skip to main content
SpringerLink
Log in

Vaskulitiden

  • Chapter
Operative und interventionelle Gefäßmedizin

  • 5510 Accesses

Zusammenfassung

Unter dem Begriff Vaskulitis versteht man eine heterogene Gruppe von Erkrankungen, deren gemeinsamer Nenner in einer Entzündung und Zerstörung der Gefäßwand besteht. Die klinische Symptomatik ist dabei oft nur zum Teil Folge der Vaskulitis selber (Fieber, CRP-Anstieg, Leukozytose, BSG-Erhöhung etc.). Vielmehr ist ein wesentlicher Teil der klinischen Symptomatik durch die sekundären Organschäden bedingt. Bei der Diagnostik von Vaskulitiden muss also meist differenzialdiagnostisch zwischen einer organspezifischen Erkrankungen und einer Organmitbeteiligung bei den meist systemischen Vaskulitiden unterschieden werden. Je nach Grunderkrankung sind Gefäße unterschiedlicher Größe und Lokalisation betroffen, was zu den verschiedenen Symptomkomplexen führt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Adu D et al. (1987) Polyarteriitis and the kidney. Quarterly Journal of Medicine 62: 221–37

    CAS  PubMed  Google Scholar 

  2. Al Dhanhani A, Macaulay R, Maloney B, Hanly JG (2006) Meningeal involvement in Wegener's granulomatois. J Rheumatol 33: 364–7

    PubMed  Google Scholar 

  3. Amann-Vesti BR, Koppensteiner R, Rainoni L, Pfamatter T, Schneider E (2003) Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteriitis. J Endovasc Ther 10(2):371–375

    PubMed  Google Scholar 

  4. Antoniu SA (2007) Treatment options for refractory Wegener's granulomatosis: a role for rituximab? Curr Opin Investig Drugs 8(11):927–932

    CAS  PubMed  Google Scholar 

  5. Ashton-Key MR, Gallagher PJ (1992) False-negative temporal artery biopsy. Am J Surg Pathol 16:634–635

    Article  CAS  PubMed  Google Scholar 

  6. Ball GV, Bridges SL Jr (2008) Vasculitis. Oxford University Press, Oxford

    Google Scholar 

  7. Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Fries JF, Leavitt RY, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 33(8):1068–1073

    Article  CAS  PubMed  Google Scholar 

  8. Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246–249

    Article  CAS  PubMed  Google Scholar 

  9. Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 1810–17

    Google Scholar 

  10. Burke AP, Virmani R (2001) Review: Localized Vasculitis. Semin Diagn Pathol 18: 59–66

    CAS  PubMed  Google Scholar 

  11. Cotch MF et al. (1996) The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution form populationbased data sources. Arthritis Rheum 39: 87–92

    Article  CAS  PubMed  Google Scholar 

  12. Evans JM, O'Fallon WM, Hunder GG (1995) Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population-Based Study. Ann Intern Med 122:502–7

    Article  CAS  PubMed  Google Scholar 

  13. Falk RJ, Hoffman GS (2007) Controversies in small vessel vasculitis – comparing the rheumatology and nephrology views. Cur Opin Rheumatol 19: 1–9

    Google Scholar 

  14. Feiner HD, Raghavendra BN, Phelps R, Rooney L (1984) Inflammatory abdominal aortic aneurysm. Report of six cases. Hum Pathol 15: 454–9

    Article  CAS  PubMed  Google Scholar 

  15. Gilmour JR (1941) Giant-cell chronic arteriitis. J Pathol 53: 263– 277

    Article  Google Scholar 

  16. Gluck T, Straub RH, Scholmerich J, Lang B (1997) Infections and vasculitis. Z Rheumatol 56(3):105–113

    Article  CAS  PubMed  Google Scholar 

  17. Guillevin L et al. (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis and Rheumatism 42: 421–30

    Article  CAS  PubMed  Google Scholar 

  18. Guillevin L, Lhote F (1995) Distinguishing polyarteriitis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 7(1):20–24

    CAS  PubMed  Google Scholar 

  19. Hellmann DB (2004) Low-dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum 50:1026–1027

    Article  PubMed  Google Scholar 

  20. Hoffman GS et al. (1992) Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488–98

    Article  CAS  PubMed  Google Scholar 

  21. Hoffman GS et al. (2002) A multicenter, randomized, doubleblind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46:1309–1318

    Article  CAS  PubMed  Google Scholar 

  22. Homme JL, Aubry M-C, Tazelaar HD, et al. (2006) Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 30: 1159–68

    Article  PubMed  Google Scholar 

  23. Hunder, GG, Arend, WP, Block, DA, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 33:1065

    Article  CAS  PubMed  Google Scholar 

  24. Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357: 2153–65

    Article  CAS  PubMed  Google Scholar 

  25. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. (1994) Proposal of an international consensus conference.Nomenclature of systemic vasculitides. Arthritis Rheum 37(2):187–192

    Article  CAS  PubMed  Google Scholar 

  26. Joseph FG, Lammie GA, Scolding NJ (2007) CNS lupus: a study of 41 patients. Neurology 69: 644–54

    Article  PubMed  Google Scholar 

  27. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined Treatment of Giant-Cell Arteritis with Methotrexate and Prednisone: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med 134:106–114

    Article  CAS  PubMed  Google Scholar 

  28. Kallenberg CG (2008) The Last Classification of Vasculitis. Clin Rev Allergy Immunol 35: 5–10

    Article  PubMed  Google Scholar 

  29. Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, Matsumoto Y, Kawakami K, Kasashima F, Moriya M, Kimura K, Ohtake H, Nakanuma Y (2008) Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 32: 197–204

    Article  PubMed  Google Scholar 

  30. Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F (2009) A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 49: 1264– 1271

    Article  PubMed  Google Scholar 

  31. Klein RG, Hunder GG, Stanson AW, Sheps SG (1975) Large artery involvement in giant cell (temporal) arteriitis. Ann Intern Med 83: 806–12

    Article  CAS  PubMed  Google Scholar 

  32. Korte MR, van Heerde MJ, de Man RA, Betjes MH (2008) Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Neth J Med 66(1):27–30

    CAS  PubMed  Google Scholar 

  33. Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: Clinical features and mortality. QJM 98(2):97– 111

    Article  CAS  PubMed  Google Scholar 

  34. Lee MS, Smith SD, Galor A, Hoffman GS (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54:3306–3309

    Article  PubMed  Google Scholar 

  35. Lie JT (1995) Aortic and extracranial large vessel giant cell arteriitis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 24: 422–31

    Article  CAS  PubMed  Google Scholar 

  36. Lim LC, Taylor JG 3rd, Schmitz JL, Folds JD, Wilkman AS, Falk RJ, et al. (1997) Diagnostic usefulnes of antineutrophil cytoplasmic autoantibody serology. Comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassay kits. Am J Clin Pathol 111: 363–9

    Google Scholar 

  37. Mackel SE, Jordon RE (1982) Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol 118: 296–301

    Article  CAS  PubMed  Google Scholar 

  38. MacLaren K, Gillespie J, Shrestha S, Neary D, Ballardie FW (2005) Primary Angiitis of the Central Nervous System: Emerging Variants. QJM 98:643–654

    Article  CAS  PubMed  Google Scholar 

  39. Maffei S, Di Renzo M, Bova G, Auteri A, Pasqui AL (2006) Takayasu's arteriitis: a review of the literature. Intern Emerg Med 1(2):105–12

    Article  PubMed  Google Scholar 

  40. Mahr A, Girard T, Agher R, Guillevin L (2005) Analysis of factors predictive of survival based on 49 patients with systemic Wegener's Granulomatosis and prospective follow-up. Rheumatology 40:492–498

    Article  Google Scholar 

  41. Miklossy J, Kunther T, Bogouslavsky J Regli F, Janzer RC (1990) Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol 80: 568–72

    Article  CAS  PubMed  Google Scholar 

  42. Miller DV, Isotalo PA; Weyand CM, Edwards WD, Aubry M-C, Tazelaar HD (2006) Surgical Pathology of Noninfectious Ascending Aortitis: A Study of 45 Cases With Emphasis on an Isolated Variant. Am J Surg Path 30: 1150–8

    Article  PubMed  Google Scholar 

  43. Mitra A, Chavan R, Gunda M (2006) Occult giant cell arteriitis and steroid therapy: how urgent is urgent? Compr Ther 32: 271–3

    Article  PubMed  Google Scholar 

  44. Molloy ES, Langford CA (2008) Vasculitis mimics. Curr Opin Rheumatol 20: 29–34

    Article  PubMed  Google Scholar 

  45. Mukhtyar C et al., for the European Vasculitis Study Group (2008) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310–17

    Google Scholar 

  46. Mukhtyar C et al., for the European Vasculitis Study Group (2008) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68: 318–23

    Google Scholar 

  47. Nesher G, Nesher R (2008) Giant cell arteritis and polymyalgia rheumatica. In: Ball GV, Bridges SL Jr (eds) Vasculitis, Chapter 24. Oxford University Press, Oxford

    Google Scholar 

  48. Olin JW, Shih A (2006) Thromboangiitis obliterans (Buerger's Disease). Curr Opin Rheumatol18:18–24

    Google Scholar 

  49. Ozaki S (2007) ANCA-associated Vasculitis: Diagnostic and Therapeutic Strategy. Allergol Int 56:87–96

    Article  CAS  PubMed  Google Scholar 

  50. Pipitone N, Salvarani C (2008) Improving therapeutic options for patients with giant cell arteriitis. Curr Opin Rheumatol 20: 17–22

    Article  CAS  PubMed  Google Scholar 

  51. Reinhold-Keller E, Beuge N, Latza U, DeGroot K, Rudert H, Nolle B, Heller M, Gross W (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Long-term outcome in 155 patients. Arthritis and Rheumatism 43: 1021–32

    Article  CAS  PubMed  Google Scholar 

  52. Reinhold-Keller E et al. (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis and Rheumatism 53: 93–9

    Article  PubMed  Google Scholar 

  53. Rodriguez-Pla A, Rossello-Urgell J, Bosch-Gil JA, Huguet-Redecilla P, Vilardell-Tarres M (2007) Proposal to decrease the number of negative temporal artery biopsies. Scand J Rheumatol 36: 111–8

    Article  CAS  PubMed  Google Scholar 

  54. Rose AG, Dent DM (2006) Inflammatory variant of abdominal atherosclerotic aneurysm. Arch Pathol Lab Med 105: 409–13: 1980

    Google Scholar 

  55. Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, Iwasaki H, Kojima M (2008) IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 32: 553–9

    Article  PubMed  Google Scholar 

  56. Salvarani C,Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteriitis. N Engl J Med 347(4):261– 271

    Article  PubMed  Google Scholar 

  57. Salvarani C et al. (2006) Giant cell arteriitis: involvement of intracranial arteries. Arthritis Rheum 55: 985–989

    Article  PubMed  Google Scholar 

  58. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62: 442–51. Comment in: Ann Neurol 62: 430–2

    Google Scholar 

  59. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG (2008) Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum 58: 595–603

    Article  PubMed  Google Scholar 

  60. Saulsbury FT (2007) Clinical update: Henoch-Schonlein purpura. Lancet 369:976–978

    Article  PubMed  Google Scholar 

  61. Schaublin GA, Michet CJ, Dyck PJ, Burns TM (2005) An Update on the Classification and Treatment of Vasculitic Neuropathy. Lancet Neurol 4:853–865

    Article  PubMed  Google Scholar 

  62. Schmidt WA (2006) Takayasu and temporal arteriitis. Front Neurol Neurosci 21: 96–104

    Article  PubMed  Google Scholar 

  63. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteriitis. Rheumatology (Oxford) 47(1):96–101

    Article  CAS  Google Scholar 

  64. Scott TF, Vandora K, Valeri A, Chieffe C, Schramke C (2007) Aggressive therapy for neurosarcoidosis: long-term follow up of 48 treated patients. Arch Neurol 64: 691–6

    Article  PubMed  Google Scholar 

  65. Segelmark M, Selga D (2007) The challenge of managing patients with polyarteriitis nodosa. Curr Opin Rheumatol 19(1):33–38

    Article  PubMed  Google Scholar 

  66. Simon RW, Fritz T, Amann-Vesti BR, Romer GS, Fischer B, Kagi MK (2005) An unusual presentation of giant cell arteriitis. Vasa 34(2):128–130

    Article  CAS  PubMed  Google Scholar 

  67. Siva A, Altintas A, Sapi S (2004) Behcet's syndrome and the nervous system. Curr Opin Neurol 17: 347–357

    Article  PubMed  Google Scholar 

  68. Sorensen SF, Slot O, Tvede N, Petersen J (2000) A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 59: 478–82

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  69. Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68: 1079–80

    Article  PubMed  Google Scholar 

  70. Steere AC (2001) Lyme disease. N Engl J Med 345: 115–25

    Article  CAS  PubMed  Google Scholar 

  71. Stone JH (2007) Vasculitis: a collection of pearls and myths. Rheum Dis Clin North Am 33: 691–739

    Article  PubMed  Google Scholar 

  72. Sueyoshi E, Sakamoto I, Uetani M (2006) MRI of Takayasu's arteriitis: typical appearances and complications. AJR Am J Roentgenol 187(6):W569–75

    Article  PubMed  Google Scholar 

  73. Tato F, Hoffmann U (2006) Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 44:176–82

    Article  PubMed  Google Scholar 

  74. Tavora F, Burke A (2006) Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology 38: 302–8

    Article  PubMed  Google Scholar 

  75. Topakian R, Stieglbauer K, Aichner FT (2007) Unexplained cerebral vasculitis and stroke: keep Lyme neuroborreliosis in mind. Lancet Neurol 6: 756–7: author reply 757: article 544–52

    Google Scholar 

  76. van der Woude FJ, Rasmussen N, Lobatto S, et al. (1985) Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1: 425–9

    Article  PubMed  Google Scholar 

  77. Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS (2007) Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore) 86: 269–77

    Article  CAS  Google Scholar 

  78. Wang G, Csernok E, de Groot K, Gross WL (1997) Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). J Immunol Methods 208: 203–11

    Article  CAS  PubMed  Google Scholar 

  79. Warrington KJ, Matteson EL (2007) Management guidelines and outcome measures in giant cell arteriitis (GCA). Clin Exp Rheumatol 25 (Suppl 47): 137–141

    CAS  PubMed  Google Scholar 

  80. Weidner N (2001) Giant-cell vasculitides. Sem Diagn Path 18: 24–33

    CAS  Google Scholar 

  81. Weyand CM, Goronzy JJ (2003) Medium- and Large-Vessel Vasculitis. N Engl J Med 349:160–169

    Article  CAS  PubMed  Google Scholar 

  82. Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteriitis as a cause of first-ever stroke. Cerebrovasc Dis 24: 226–30

    Article  PubMed  Google Scholar 

  83. Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B, Czarnacki M, Doskocz R, Kowal-Gierczak B (2000) Sustained Classic Clinical Spectrum of Thromboangiitis Obliterans (Buerger's Disease). Angiology 51:141–150

    Article  CAS  PubMed  Google Scholar 

  84. Yazici H, Fresko I, Yurdakul S (2007) Behcet's Syndrome: Disease Manifestations, Management and Advances in Treatment. Nat Clin Pract Rheumatol 3:148–155

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsspital Zürich, Rämistrasse 100, 8091, Zürich, Schweiz

    Prof. Dr. med. B. Amann-Vesti

  2. Klinik für Immunologie MOU 19, Universitätsspital Zürich, Rämistrasse 100, 8091, Zürich, Schweiz

    Prof. Dr. med. A. Fontana

  3. Gefäßzentrum Innenstadt – Medizinische Poliklinik, Klinikum der Universität München, Pettenkoferstraße 8a, 80336, München

    PD Dr. med. P. Kuhlencordt

  4. Pathologisches Institut der Universität, Luitpoldkrankenhaus, Josef-Schneider Straße 2, 97080, Würzburg

    Prof. Dr. med. J. G. Müller

Authors
  1. Prof. Dr. med. B. Amann-Vesti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. A. Fontana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. PD Dr. med. P. Kuhlencordt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. med. J. G. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Gefäßmedizin, Universitäres Herzzentrum GmbH, Universitätsklinikum Hamburg-Eppendorf, Hamburg

    E. Sebastian Debus

  2. GefäßCentrum Hamburg (GCH), ASKLEPIOS KLINIK Harburg, Hamburg

    Walter Gross-Fengels

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Amann-Vesti, B., Fontana, A., Kuhlencordt, P., Müller, J. (2012). Vaskulitiden. In: Debus, E., Gross-Fengels, W. (eds) Operative und interventionelle Gefäßmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01709-4_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01709-4_45

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01708-7

  • Online ISBN: 978-3-642-01709-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation